AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing

RecruitingPhase 4Ages 18 Years - 65 YearsAllULURU Inc.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Hospitalized patients who are receiving burn care; patients may be discharged when clinically stable and continue with outpatient treatment. * Men and women (women cannot be pregnant or breast feeding) ages 18-65 years old * Wounds must be partial thickness, involving up to 20% of the total body surface area. * Burn injury should be less than 72 hours old * Willing and able to comply with protocol mandated scheduled study visits/clinical evaluations. * Willing and able to provide written informed consent. Exclusion Criteria: * Known allergy to TPD or its components * Women who are pregnant, breast feeding, or plan to get pregnant during the study period. * Infected wounds * Presence of any full thickness (third degree) burns * Electrical burns * Heavily draining burns due to underlying chronic lymphedema or other conditions * Concurrent clinical condition within the judgement of the clinician, pose a health risk to the patient, delay wound healing, or otherwise influence the outcome of the study. * History of poor wound healing and/or skin/immune system condition * Deemed by clinician not to be suitable * Unwilling or not able to provide consent or comply with protocol or required visits * Developmental disability/significant psychological disorder which can impair the subjects ability to provide informed consent, or participate in the study protocol * Active alcohol or substance abuse
๐Ÿ’Š

What it tests

  • Altrazeal (R) Transforming Powder Dressing
  • Standard of Care burn dressing
๐Ÿ“

Where

6 sites
University of California-Irvine
Orange, United States
MedStar Washington Hospital Center
Washington D.C., United States
Jackson Memorial Hospital UM/JMH Burn Center
Miami, United States
University of Louisville Health
Louisville, United States
Westchester Medical Center
Valhalla, United States
University of Texas SW (Parkland)
Dallas, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy